Redeye: THQ Nordic - The best is yet to come!

The Q2 report beat our projections on all accounts, primarily due to solid catalog sales. The pipeline and release schedule for H2 2017 looks extremely promising; we continue to believe that the sales during Q4 will be on par or above the total sales of 2016.

Read more and download the Research Update: https://goo.gl/wEQMDW

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/